<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02831946</url>
  </required_header>
  <id_info>
    <org_study_id>0062-16-MMC</org_study_id>
    <nct_id>NCT02831946</nct_id>
  </id_info>
  <brief_title>Suture Versus Glue (Dermabond) Closure During Cesarean Delivery</brief_title>
  <acronym>SVGCS</acronym>
  <official_title>Intracuticular Sutures Versus Glue (Dermabond) for Skin Closure After Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effect of intracutaneous suture closure versus Glue (dermabond) closure at
      cesarean section (CS) on long-term cosmetic and maternal outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women undergoing planned CS were randomized to either intracutaneous suture closure or glue
      closure using a 1:1 allocation algorithm. Participants and outcome assessors were blinded to
      group allocation. Scar evaluation was performed after two months.

      Primary outcome measures were Patient and Observer Scar Assessment Scale (POSAS) summary
      scores 2 months after surgery. Secondary outcome measures were, duration of surgery, and
      development of hematoma, seroma, surgical site infection (SSI) or wound disruption.

      Data were analyzed according to the intention to treat principle.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient and Observer Scar Assessment Scale (POSAS)</measure>
    <time_frame>2 month</time_frame>
    <description>Subjective scar rating will be performed using the patient component of the POSAS. The POSAS Scale consists of 2 numerical numeric scales: The Patient Scar Assessment Scale and the Observer Scar Assessment Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>post operative complication</measure>
    <time_frame>1 month</time_frame>
    <description>Development of surgical site infection or wound disruption.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Adhesive; Band</condition>
  <condition>Suture; Complications</condition>
  <arm_group>
    <arm_group_label>MODIFIED VICRYL PLUS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intra-cuticular layer will closed with with VICRYL PLUS suture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DERMABOND GLUE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intra-cuticular layer will closed with with DERMABOND GLUE</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MODIFIED VICRYL PLUS</intervention_name>
    <description>closing the intra-cuticular layer with MODIFIED VICRYL PLUS suture</description>
    <arm_group_label>MODIFIED VICRYL PLUS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DERMABOND GLUE</intervention_name>
    <description>closing the intra-cuticular layer with Dermabond glue</description>
    <arm_group_label>DERMABOND GLUE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women between 18 and 45 years

          -  Elective cesarian section

        Exclusion Criteria:

          -  Clinical signs of infection at the time of CS

          -  History of keloids and a medical disorder that could affect wound healing

          -  Hypersensitivity to any of the suture materials used in the protocol

          -  Diabetes mellitus

          -  Disorders requiring chronic corticosteroid use or immunosuppression
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reut Ohana</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meir Helsinki</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yair M Daykan, MD</last_name>
    <phone>972-542198231</phone>
    <email>yair.dykan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Reut Ohana</last_name>
    <phone>972-9-7471588</phone>
    <email>reut.ohana@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar Saba,</city>
        <zip>11125</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yair M Daykan, MD</last_name>
      <phone>972-54-2198231</phone>
      <email>yair.dykan@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2016</study_first_submitted>
  <study_first_submitted_qc>July 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2016</study_first_posted>
  <last_update_submitted>July 11, 2016</last_update_submitted>
  <last_update_submitted_qc>July 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>Yair Daykan</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>skin closure</keyword>
  <keyword>intracuticular suture</keyword>
  <keyword>glue (dermabond)</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>within 6 m of finishing the study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

